eXoZymes Inc
EXOZ
7 hedge funds and large institutions have $472K invested in eXoZymes Inc in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 7 → 7 (0)
0% more ownership
Funds ownership: 0.75% → 0.75% (+0%)
31% less capital invested
Capital invested by funds: $682K → $472K (-$211K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12K |
| 2 |
BlackRock
New York
|
+$4.99K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$192 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$15.3K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$185 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VCM
1
Vanguard Capital Management
Malvern,
Pennsylvania
| $166K | +$203K | +22,190 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $164K | -$15.3K | -1,671 | -7% |
|
|
VFT
3
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
| $70.7K | +$86.2K | +9,426 | New |
|
|
4
BlackRock
New York
| $51K | +$4.99K | +546 | +9% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $9.89K | +$12K | +1,315 | +65,750% |
|
6
Morgan Stanley
New York
| $9.39K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $180 | +$192 | +21 | +700% |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | -$185 | -17 | Closed |
|
EXOZ Hedge Fund Activity: Q1 2026 in Review
7 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in eXoZymes Inc (EXOZ) for Q1 2026, worth a combined $472K — down 31% from $682K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new EXOZ positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $12K. The largest seller was Geode Capital Management, cutting an estimated $15.3K.
- 7 institutional investors held eXoZymes Inc (EXOZ) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $472K of eXoZymes Inc stock for Q1 2026, down 31% quarter-over-quarter.
- 2 funds opened new eXoZymes Inc positions in Q1 2026 and 1 closed out, a net change of +1 holder.
- The largest eXoZymes Inc buyer in Q1 2026 was Tower Research Capital (TRC), an estimated $12K added.
- The largest eXoZymes Inc seller in Q1 2026 was Geode Capital Management, an estimated $15.3K sold.
Based on aggregated 13F filings for Q1 2026.